Wikidata entity: Q66068701
Quantities
| P4135 | maximum age | 90 |
| P2899 | minimum age | 18 |
| P1132 | number of participants | 15 |
| P6099 | clinical trial phase | ... | Q42825046 (phase IV clinical trial) | phase IV clinical trial |
| P17 | country | ... | Q38 (Italy) | Italy |
| P582 | end time | ... | 2017-12-31 | ??? |
| P31 | instance of | ... | Q30612 (clinical trial) | clinical trial |
| P1050 | medical condition | ... | Q1752891 (polymyalgia rheumatica) | polymyalgia rheumatica |
| P580 | start time | ... | 2015-01-01 | ??? |
| P8363 | study type | ... | Q78089383 (interventional study) | interventional study |
| P1476 | title | Monolingualtext | Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission: a Prospective, Pilot Study. | ??? |
| P3098 | ClinicalTrials.gov ID | NCT03244709 |
Why not click here or view trends?
log id: 4842596